Search Orphan Drug Designations and Approvals
-
Generic Name: | Tempol |
---|---|
Date Designated: | 07/21/2021 |
Orphan Designation: | Treatment of Ataxia Telangiectasia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Matrix Biomed, Inc. 2600 Michelson Dr. Suite 1700 Irvine, California 92612 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-